Free Trial

Cabaletta Bio (CABA) SEC Filings & 10K Form

Cabaletta Bio logo
$4.07
+0.07 (+1.75%)
(As of 10:54 AM ET)

Recent Cabaletta Bio SEC Filings

DateFilerForm TypeView
10/17/2024
11:00 AM
Cabaletta Bio (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
10/07/2024
5:06 AM
Cabaletta Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
3:30 PM
Cabaletta Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2024
5:10 PM
Bain Capital Life Sciences Opportunities III, LP (Filed by)
Cabaletta Bio (Subject)
Form SC 13G
08/08/2024
6:25 AM
Cabaletta Bio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
6:07 AM
Cabaletta Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
5:06 AM
Cabaletta Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2024
12:01 PM
Cabaletta Bio (Subject)
JENNISON ASSOCIATES LLC (Filed by)
Form SC 13G
06/04/2024
6:27 PM
Bollard Catherine (Reporting)
Cabaletta Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
6:14 PM
Cabaletta Bio (Issuer)
Tomasello Shawn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
6:17 PM
Brun Scott C. (Reporting)
Cabaletta Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
6:21 PM
Cabaletta Bio (Issuer)
HENRIQUES RICHARD C JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
6:21 PM
Cabaletta Bio (Issuer)
Simon Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
3:32 PM
Cabaletta Bio (Filer)
Cabaletta Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
6:53 AM
Cabaletta Bio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/15/2024
6:04 AM
Cabaletta Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2024
6:00 AM
Cabaletta Bio (Filer)
Form DEF 14A
04/23/2024
6:05 AM
Cabaletta Bio (Filer)
Form DEFA14A
04/23/2024
6:10 AM
Cabaletta Bio (Filer)
Form ARS
03/21/2024
7:02 AM
Cabaletta Bio (Filer)
Form S-3ASR
03/21/2024
6:51 AM
Cabaletta Bio (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/21/2024
6:24 AM
Cabaletta Bio (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/21/2024
6:12 AM
Cabaletta Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2024
6:11 AM
Cabaletta Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2024
4:45 PM
Cabaletta Bio (Issuer)
Chang David J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
4:50 PM
Cabaletta Bio (Issuer)
Gerard Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
4:36 PM
Cabaletta Bio (Issuer)
Das Arun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
4:36 PM
Cabaletta Bio (Issuer)
Marda Anup (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
4:40 PM
Cabaletta Bio (Issuer)
Nichtberger Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
4:28 PM
Binder Gwendolyn (Reporting)
Cabaletta Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:53 PM
Cabaletta Bio (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SC 13G/A
02/14/2024
8:20 AM
Cabaletta Bio (Subject)
Lynx1 Capital Management LP (Filed by)
Form SC 13G/A
02/13/2024
5:47 PM
Bain Capital Life Sciences Opportunities III, LP (Filed by)
Cabaletta Bio (Subject)
Form SC 13G/A
02/12/2024
4:25 PM
Cabaletta Bio (Subject)
Flynn James E (Filed by)
Form SC 13G/A
02/07/2024
6:04 AM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Cabaletta Bio (Subject)
Form SC 13G/A
02/01/2024
3:36 PM
Cabaletta Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2024
9:07 AM
Cabaletta Bio (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
01/19/2024
5:30 PM
Binder Gwendolyn (Reporting)
Cabaletta Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
3:35 PM
BlackRock Inc. (Filed by)
Cabaletta Bio (Subject)
Form SC 13G
01/08/2024
6:11 AM
Cabaletta Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2023
7:37 PM
Binder Gwendolyn (Reporting)
Cabaletta Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

11/20/2023
3:16 PM
Binder Gwendolyn (Reporting)
Cabaletta Bio (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/09/2023
6:12 AM
Cabaletta Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
6:24 AM
Cabaletta Bio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2023
6:03 AM
Cabaletta Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CABA) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners